These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26227007)

  • 1. Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases.
    Moreno Romero JA; Campoy A; Perez N; Garcia F; Grimalt R
    Br J Dermatol; 2015 Dec; 173(6):1514-7. PubMed ID: 26227007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rapidly growing squamous cell carcinoma after ingenol mebutate treatment].
    Ehret M; Velter C; Tebacher M; Bruant-Rodier C; Cribier B
    Ann Dermatol Venereol; 2018 Oct; 145(10):607-612. PubMed ID: 29779859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Response to Ingenol Mebutate in Patients With Actinic Keratoses.
    Batalla A; Flórez Á; Feal C; Peón G; Abalde MT; Salgado-Boquete L; de la Torre C
    Actas Dermosifiliogr; 2015 Dec; 106(10):e55-61. PubMed ID: 26055975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
    Bettencourt MS
    J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local skin reactions following the administration of topical ingenol mebutate for actinic keratosis.
    Conde-Taboada A; Mercado B; Aranegui B; González-Guerra E; López-Bran E
    Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and side effects in patients with actinic keratosis treated with ingenol mebutate: a pilot study.
    Jubert-Esteve E; Del Pozo-Hernando LJ; Izquierdo-Herce N; Bauzá-Alonso A; Martín-Santiago A; Jones-Caballero M
    Actas Dermosifiliogr; 2015 Oct; 106(8):644-50. PubMed ID: 26130156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.
    Pellacani G; Peris K; Guillen C; Clonier F; Larsson T; Venkata R; Puig S
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2192-8. PubMed ID: 26300464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
    Erlendsson AM
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis.
    Sinnya S; Tan JM; Prow TW; Primiero C; McEniery E; Selmer J; Østerdal ML; Soyer HP
    Br J Dermatol; 2016 Feb; 174(2):305-11. PubMed ID: 26499175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
    Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
    JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
    Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N
    J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma developed after ingenol mebutate therapy: a possible consequence of the treatment?
    Maglie R; Grandi V; Maio V; Pileri A
    G Ital Dermatol Venereol; 2018 Jun; 153(3):442-443. PubMed ID: 29766707
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial.
    Erlendsson AM; Karmisholt KE; Haak CS; Stender IM; Haedersdal M
    J Am Acad Dermatol; 2016 Apr; 74(4):709-15. PubMed ID: 26810403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
    Abramovits W; Oquendo M; Vincent KD; Gupta AK
    Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives.
    Gameiro L; Tovo LFR; Sanches Júnior JA; Aprahamian I
    An Bras Dermatol; 2019 Jul; 94(3):313-319. PubMed ID: 31365660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face.
    Jim On SC; Hashim PW; Nia JK; Lebwohl MG
    J Drugs Dermatol; 2017 May; 16(5):432-436. PubMed ID: 28628678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
    Berman B
    Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.